A Clinical Case of Hypogonadism and Anosmia Associated with a New Mutation of the KAL1/ ANOS1 Gene

A Clinical Case of Hypogonadism and Anosmia Associated with a New Mutation of the KAL1


Introduction
Kallmann syndrome (KS) is a genetic disorder characterized by the association of GnRH deficiency resulting in congenital hypogonadotropic hypogonadism (CHH) and anosmia or hyposmia. CHH is an uncommon and clinically heterogeneous group of disorders characterized by isolated gonadotropin deficiency of varying degree with normal pituitary function leading to absent or incomplete puberty and infertility [1,2]. The first genetic cause of KS was identified in 1991 and the estimated incidence of this syndrome is 1:30,000 in men and 1:125,000 in women [3,4]. The severity of the disease in patients with KS significantly varies among individuals, depending on different affected genes and modes of inheritance [5,6]. The most frequent allelic variant in the X-linked form occurs in the KAL1/ANOS1 gene. The KAL1/ANOS1 gene encodes anosmin 1, a glycoprotein of embryonic extracellular matrices that is involved in fibroblast growth factor (FGF) signaling [7,8]. Other inherited patterns can be classic Mendelian ones (autosomal dominant or recessive) or more complex as in multifactorial/multigenic diseases [5]. KS is associated with numerous candidate genes and mutations can explain approximately 50% of all cases. Differential diagnosis is often made with other rare genetic diseases such as CHARGE syndrome (CS) which includes hypogonadism, hyposmia, and several organ defects. CS is a rare autosomal dominant syndrome caused by mutations of the Chromodomain helicase DNA binding protein 7 (CHD7) gene [9]. The estimated incidence of CS is 1:8500 live births [3]. Signs associated with CS include Coloboma, Heart defects, Atresia of choanae, Retardation of growth and development, Genital and urinary defects, Ear anomalies, and deafness. Subjects with these characteristics should be screened for mutations in CHD7. Mutations of the CHD7 gene have also been described in approximately 6% of patients with CHH [1].
Here we report a clinical case of a patient with a clinical diagnosis of KS in which a new genetic KAL1/ANOS1 gene variant was found to be associated with a rare mutation of the CHD7 gene.

Case presentation
A 48-year-old male patient was referred to our endocrinology service for evaluation of hypogonadism. The medical history of the patient started when he was 17 years old. At that time patient was diagnosed with hypogonadotropic hypogonadism (LH <0.07mUI/ mL; FSH <0.3 mUI/mL, Testosterone 3.17 ng/dL) and anosmia wherefore placed on testosterone replacement therapy to induce its pubertal development. At the time of the visit to our service, the patient reported a lack of compliance with intramuscular testosterone therapy over the years and was therefore placed again on therapy. Testosterone was topically administered at a dose of 40 mg per day and dose adjustments were made according to its hematic testosterone levels. No genetic tests had been conducted until our visit on suspicion of KS. Patient characteristics are reported in Table 1    It was requested to investigate the presence of KS also in family members, but it was not possible because at the time of the genetic evaluation, the parents had died and there were no siblings to investigate. No other suspected anomalous cases of KS or CS were described in the family.

Discussion
KS is a condition characterized by CHH and an impaired sense of smell of various degrees. KS can have additional signs and symptoms such as cardiovascular disease, metabolic syndrome, osteoporosis, psychological disorders, and renal or dental abnormalities [2,10,11]. Several genes mutated in KS affect the migration of GnRH neurons [5]. CHH and anosmia are frequent features also in other rare genetic disorders such as CS and it could be possible that the same embryonic migration process is altered in both syndromes. In particular, CHD7 gene encodes a protein of the chromodomain family that can play an important role in regulating embryonic development [12]. On the other hand, during embryonic development, GnRH neurons migrate alongside the olfactory axons toward the hypothalamus, and protein products of KAL1/ANOS1 genes are thought to be involved in this migration process [13,14].
Both KAL1/ANOS1 and CHD7 genes are known to be important causal genes in the development of KS. Mutation in the CHD7 gene can be found in approximately 75 % of CS patients and in 6-8% of patients with KS [1,3,5]. KS and CS are clinically highly variable characteristics and differential diagnosis between these two diseases should be considered in patients with anosmia and hypogonadism. Some authors have hypothesized that CHH can be a variant of CS and that to date the correlation between the CS phenotype and the CHD7 mutation in KS is not completely clear [15,16].
The diagnosis of KS and CS is based on the clinical and hormonal evaluation of the patients, while the genetic analysis is useful for confirming the molecular diagnosis of the two syndromes. Males born with CHH can have micropenis and cryptorchidism. At puberty, male patients may not develop secondary sexual characteristics such as the growth of facial hair and deepening of the voice, while adults can have infertility. In the present case, the patient showed hypogonadotropic hypogonadism and anosmia treated with testosterone replacement to induce pubertal development during his adolescence. The MR confirmed the radiological diagnosis of KS showing the absence of the olfactory bulbs and the olfactory sulcus in the left frontobasal area. Moreover, the patient had been found to harbor two mutations in adulthood in KAL1/ANOS1 and CHD7 genes. Until now p.R46H variant in KAL1/ANOS1 gene has never been reported, while p.L2806V variant was described in the literature to be associated with less severe forms of CS and with incomplete CS features [17,18]. Our results confirm the incomplete penetrance of this CHD7 variant which might contribute together with the novel KAL1/ ANOS1 to the KS phenotype of this patient.
In conclusion, here we report a case of KS associated with an unprecedented oligogenic involvement, a new variant in the KAL1/ ANOS1 gene, and a rare heterozygous variant in the CHD7 gene. KS is a rare condition that must be considered for the management of patients with hypogonadism and anosmia and differential diagnosis should be made with other rare genetic diseases such as CS.
Declaration of Interest: MDP, FM, GDS, FV, and LG have no financial interest to report.

Funding:
The study was partially supported by the Italian Ministry of Health, Rome, Italy (code: 05C202_2012).

Patient Consent:
Written informed consent has been obtained from the patient for publication of this report.